Formula: | C19H21ClFN5O4 |
Molecular Weight: | 437.86 |
Rotatable Bond Donors: | 4 |
clogP: | 2.28 |
Topological Polar Surface Area: | 100.80 |
Lipinski's RO5: | MW: 437.86 HBA: 9 HBD: 1 RB: 4 LogP: 2.28 |
Rule of Three: | MW: 437.86 HBA: 9 HBD: 1 RB: 4 LogP: 2.28 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS18053 | 0.7 | EOS18053 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -4.2817 -4.7558 -1.0118 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0396 -4.0674 -1.0488 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.9736 -3.4043 -2.3001 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4321 -1.9517 -2.2339 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4044 -1.5591 -2.8769 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.6891 -1.1203 -1.4321 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.0487 0.2713 -1.2815 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2211 0.7576 -0.1156 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8452 2.1694 -0.2357 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8903 3.1153 0.6735 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3953 4.1912 -0.0134 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2449 5.5185 0.5972 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0550 3.9485 -1.2837 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3553 2.5942 -1.4380 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0990 -0.2474 -0.0012 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5714 -1.5511 -0.6177 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3039 0.1244 -0.4925 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7679 -0.0967 0.8618 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9682 -0.6079 1.2811 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1154 -1.1414 2.3780 O 0 0 0 0 0 0 0 0 0 0 0 0 2.9797 -0.4674 0.3558 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3108 -0.9191 0.6575 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0180 0.0549 1.5726 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3850 -0.4649 1.9473 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8717 0.2548 3.1807 C 0 0 0 0 0 0 0 0 0 0 0 0 7.3628 -0.2309 0.8205 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5366 -0.4148 1.4076 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 11 13 2 0 13 14 1 0 8 15 1 0 15 16 1 0 15 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 19 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 24 25 1 0 24 26 1 0 18 27 1 0 16 6 1 0 14 9 1 0 27 15 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |